Modulated release from biocompatible polymers
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/14
A61K-009/16
출원번호
US-0039285
(2002-01-03)
발명자
/ 주소
Bernstein, Howard
Zhang, Yan
Khan, M. Amin
Tracy, Mark A.
출원인 / 주소
Alkermes Controlled Therapeutics, Inc.
대리인 / 주소
Hamilton, Brook, Smith & Reynolds, P.C.
인용정보
피인용 횟수 :
32인용 특허 :
39
초록▼
The present invention relates to a composition for the modulated release of a biologically active agent. The composition comprises a biocompatible polymeric matrix, a biologically active agent which is dispersed within the polymeric matrix, and a metal cation component which is separately dispersed
The present invention relates to a composition for the modulated release of a biologically active agent. The composition comprises a biocompatible polymeric matrix, a biologically active agent which is dispersed within the polymeric matrix, and a metal cation component which is separately dispersed within the polymeric matrix, whereby the metal cation component modulates the release of the biologically active agent from the polymeric matrix. The present invention also relates to a method for modulating the release of a biologically active agent from a biocompatible polymeric matrix, comprising the steps of dissolving a biocompatible polymer in a solvent to form a polymer solution and also separately dispersing a metal cation component and a biologically active agent within the polymer solution. The polymer solution is then solidified to form a polymeric matrix, wherein at least a significant portion of the metal cation component is dispersed in the polymeric matrix separately from the biologically active protein, and whereby the metal cation component modulates the release of the biologically active agent from the polymeric matrix.
대표청구항▼
1. A composition for the modulated release of a biologically active pharmaceutical agent, comprising: a) a biocompatible and biodegradable polymeric matrix; b) an effective amount of a biologically active pharmaceutical agent, the biologically active pharmaceutical agent being dispersed within
1. A composition for the modulated release of a biologically active pharmaceutical agent, comprising: a) a biocompatible and biodegradable polymeric matrix; b) an effective amount of a biologically active pharmaceutical agent, the biologically active pharmaceutical agent being dispersed within the polymeric matrix; and c) a metal cation component for modulating the release of the biologically active agent from the polymeric matrix, wherein said metal cation component is selected from the group consisting of magnesium hydroxide, magnesium carbonate, calcium carbonate, zinc carbonate, magnesium acetate, zinc acetate, magnesium chloride, zinc chloride, magnesium sulfate, zinc sulfate, magnesium citrate and zinc citrate, the metal cation component is separately dispersed within the polymeric matrix and the biologically active agent is present from about 0.01% (w/w) to about 50% (w/w) of the composition. 2. A modulated release composition of claim 1 wherein said biodegradable and biocompatible polymer is selected from the group consisting of poly(lactide)s, poly(glycolide)s, poly(lactide-co-glycolide)s polyanhydrides, polyorthoesters, polyetheresters, polycaprolactone, polyesteramides, blends and copolymers thereof.3. A modulated release composition of claim 2 wherein said biologically active agent comprises a protein.4. A modulated release composition of claim 3 wherein said protein is selected from the group consisting of nucleases, erytihropoietin, human growth hormone, interferons, interleukins, growth factors, tumor necrosis factor, adrenocorticotropic hormone, and colony-stimulating factors.5. A composition for the modulated release of a biologically active agent, comprising: a) a biocompatible polymeric matrix of a polymer selected from the group consisting of poly(lactide)s, poly(glycolide)s, poly(lactide-co-glycolide)s and blends thereof, b) an effective amount of a biologically active protein, said biologically active protein being dispersed within the polymeric matrix; and c) a metal cation component for modulating release of the biologically active agent from the polymeric matrix, wherein said metal cation component is selected from the group consisting of magnesium hydroxide, magnesium carbonate, calcium carbonate, zinc carbonate, magnesium acetate, zinc acetate, magnesium sulfate, zinc sulfate, magnesium chloride, zinc chloride, zinc citrate and magnesium citrate, the metal cation component is separately dispersed within the polymeric matrix and the biologically active protein is present from about 0.01% (w/w) to about 50% (w/w) of the composition. 6. A modulated release composition of claim 5 wherein said biologically active protein is selected from the group consisting of nucleases, erythropoietin, human growth hormone, interferons, interleukins, growth factors, adrenocorticotropic hormone, tumor necrosis factor and colony-stimulating factors.7. A method for modulating the release of a biologically active agent from a polymeric matrix, comprising: a) dissolving a biocompatible polymer in a solvent to form a polymer solution; b) dispersing a metal cation component in said solvent, wherein the metal cation component comprises a metal cation selected from the group consisting of Zn(II), Mg(II) and a combination of at least two different multivalent metal cations; c) separately dispersing a biologically active agent in said polymer solution; and d) solidifying said polymer from said polymer solution to form a polymeric matrix, whereby the metal cation component modulates the release of the biologically active agent from the polymeric matrix and the biologically active agent is present from about 0.01% (w/w) to about 50% (w/w). 8. A method of claim 7 wherein said biologically active agent comprises a protein.9. A method of claim 8 wherein said protein is selected from the group consisting of nucleases, erythropoietin, human growth hormone, interferons, interleukins, growth factors, adrenocor ticotropic hormone, tumor necrosis factor and colony-stimulating factors.10. A method of claim 9 wherein said polymer is biodegradable.11. A method of claim 10 wherein said biodegradable polymer is selected from the group consisting of poly(lactide)s, poly(glycolide)s, poly(lactide-co-glycolide)s, polyanhydrides, polyorthoesters, polyetheresters, polycaprolactone, polyesteramides, blends and copolymers thereof.12. A method of claim 7, further comprising the step of dissolving said metal cation component in a second solvent before dispersing the metal cation component in the polymer solution, wherein the second solvent is miscible with the first solvent, and wherein said polymer is soluble in the second solvent.13. A method of delivering a biologically active agent to an individual in need thereof comprising the step of administering to said patient a composition for the modulated release of a biologically active agent comprising: a) a biocompatible polymeric matrix; b) an effective amount of a biologically active agent, wherein the biologically active agent is dispersed within the polymeric matrix; and c) one or more metal cation components for modulating release of the biologically active agent from the polymeric matrix wherein the metal cation component comprises a cation selected from the group consisting of Zn(II), Mg(II) and a combination of at least two different multivalent metal cations, the metal cation component is separately dispersed within the polymeric matrix and the biologically active agent is present from about 0.01% to about 50% (w/w) of the composition. 14. The method of claim 13 wherein said metal cation component is selected from the group consisting of magnesium hydroxide, magnesium carbonate, zinc carbonate, magnesium acetate, zinc acetate, magnesium chloride, zinc chloride, magnesium sulfate, zinc sulfate, magnesium citrate and zinc citrate.15. The method of claim 13 wherein said polymer is a biodegradable polymer.16. The method of claim 15 wherein said biodegradable polymer is selected from the group consisting of poly(lactide)s, poly(glycolide)s, poly(lactide-co-glycolide)s, poly(lactic acid)s, poly(glycolic acid)s, poly(lactic acid-co-glycolic acid)s, polyanhydrides, polyorthoesters, polyetheresters, polycaprolactone, polyesteramides, blends and copolymers thereof.17. The method of claim 13 wherein said biologically active agent is a protein selected from the group consisting of nucleases, erythropoietin, human growth hormone, interferons, interleukins, growth factors, tumor necrosis factor, adrenocorticotropic hormone, and colony-stimulating factors.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (39)
Leong Kam W. (Ellicott City MD), Biocompatible and biodegradable poly (phosphoester-urethanes).
Langer Robert S. (Somerville MA) Rosen Howard (Montara CA) Linhardt Robert J. (Iowa City IA) Leong Kam (Cambridge MA), Bioerodible polyanhydrides for controlled drug delivery.
Lane George A. (Midland MI) Rossow Harold E. (Midland MI), Biologically-active compounds comprising a biologically-active anionic portion and a water-insoluble, inorganic cationic.
Tice Thomas R. (Birmingham AL) Lewis Danny H. (Gardendale AL) Cowsar Donald R. (Birmingham AL) Beck Lee R. (Birmingham AL), Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents.
Tice, Thomas R.; Lewis, Danny H.; Cowsar, Donald R.; Beck, Lee R., Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents.
Cardarelli Nathan F. (Barberton OH), Method and composition for the long term controlled release of a non-persistent organotin pesticide from an inert monoli.
Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
Bernstein Howard (Cambridge MA) Zhang Yan (Cambridge MA) Khan M. Amin (Downingtown PA) Tracy Mark A. (Arlington MA), Modulated release from biocompatible polymers.
Ron Eyal (Lexington MA) Chasin Mark (Englishtown NJ) Turek Tom (Dorchester MA) Langer Robert S. (Newton MA), Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone.
Tice Thomas R. (Birmingham AL) Orsolini Piero (Martigny LA CHX) Schally Andrew V. (New Orleans LA), Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases.
Rueger David C. (Hopkinton MA) Kuberasampath Thangavel (Medway MA) Oppermann Hermann (Medway MA) Ozkaynak Engin (Milford MA), Prosthetic devices having enhanced osteogenic properties.
Orsolini Piero (Martigny) Mauvernay Rolland-Yves (Lausanne) Deghenghi Romano (Lausanne CHX), Sustained and controlled release of water insoluble polypeptides.
Gombotz Wayne R. (Lexington MA) Healy Michael S. (E. Bridgewater MA) Brown Larry R. (Newton MA), Very low temperature casting of controlled release microspheres.
Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakis, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
Brown, Larry R.; Bisker-Leib, Vered; Scott, Terrence L.; Lafreniere, Debra; Machen, Jennifer; Giannoukakls, Nick, Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes.
Brown, Larry; McGeehan, John K.; Rashba-Step, Julia; Scott, Terrence L., Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation.
Costantino, Henry R.; Hotz, Joyce M.; Dasch, James R.; Riley, M. Gary I.; Burke, Paul A.; Steitz-Abadi, Susan A.; Zale, Stephen E., Microencapsulation and sustained release of biologically active polypeptides.
Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R.; Smith, Christine; Lokensgard, David M.; Fineman, Mark; Ong, John, Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar.
Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R., Polymer-based sustained release device.
Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R., Polymer-based sustained release device.
Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R., Polymer-based sustained release device.
Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R., Polymer-based sustained release device.
Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Costantino, Henry R., Polymer-based sustained release device.
Wright, Steven G.; Christensen, Troy; Yeoh, Thean; Rickey, Michael E.; Hotz, Joyce M.; Kumar, Rajesh; Fineman, Mark; Smith, Christine; Ong, John; Lokensgard, David M.; Costantino, Henry R., Polymer-based sustained release device.
Brown, Larry; Bisker-Leib, Vered; LaFreniere, Debra; McGeehan, John; Rashba-Step, Julia; Scott, Terrence, Protein microspheres having injectable properties at high concentrations.
Tarara, Thomas E.; Weers, Jeffrey G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Pulmonary delivery particles comprising an active agent.
Dellamary, Luis A.; Reiss, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery.
Dellamary, Luis A; Riess, Jean; Schutt, Ernest G; Weers, Jeffry G; Tarara, Thomas E, Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.